Related Experiment Video
Updated: Jun 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
GANomics: bridging legacy and modern transcriptomic platforms for clinical applications
Leihong Wu1, Hadi Salman2,3, Weida Tong2
1Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, FDA, Jefferson, AR, USA. leihong.wu@fda.hhs.gov.
GANomics, a generative adversarial network (GAN), translates between microarray and RNA-seq transcriptomic data. This framework effectively integrates historical and modern datasets for enhanced biomarker discovery and clinical applications.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Transcriptomic technologies have evolved, necessitating methods to integrate legacy microarray data with modern RNA-sequencing (RNA-seq) data.
- Leveraging historical transcriptomic datasets is crucial for comprehensive analysis and biomarker discovery.
- Existing methods may struggle with accurate data translation between different transcriptomic platforms.
Purpose of the Study:
- To develop a robust framework, GANomics, for bidirectional data translation between microarray and RNA-seq platforms.
- To enable the effective integration of historical and contemporary transcriptomic data while preserving biological consistency.
- To facilitate the reuse of biomarkers and expand transcriptomic resources for clinical applications.
Main Methods:
- Utilized a generative adversarial network (GAN) framework named GANomics.
- Integrated paired and unpaired samples using a pair-aware feedback loss mechanism.
- Enforced one-to-one transcript mappings and preserved global gene expression distributions during data translation.
Main Results:
- Achieved high per-sample correlations (>0.96) between real and synthetic data with as few as ten paired profiles.
- Accurately recapitulated differential gene expression and maintained pathway-level rankings with fifty paired profiles.
- Enabled a cross-platform classifier to transfer with performance comparable to real data, demonstrating robustness across multiple datasets.
Conclusions:
- GANomics effectively bridges legacy and contemporary transcriptomic data, retaining biological consistency.
- The framework facilitates scalable data integration for biomarker reuse and enhances transcriptomic resource expansion in clinical settings.
- GANomics offers a powerful solution for leveraging historical transcriptomic data alongside modern datasets.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Genomics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Pharmacogenomics: Identification of New Drug Targets
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenetics and Pharmacogenomics: Overview
Modern Molecular Taxonomy